K.G. Jebsen - Thrombosis Research and Expertise Center (TREC), Department of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø, Norway.
Medical division, Østfold Hospital, Sarpsborg, Norway; Department of Hematology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Thromb Res. 2020 Jul;191:134-139. doi: 10.1016/j.thromres.2020.04.026. Epub 2020 Apr 25.
Current guidelines recommend the use of clinical decision rules, such as Wells score, in combination with D-dimer to assess the need for objective imaging to rule out deep vein thrombosis (DVT). However, the clinical decision rule has limitations, and use of D-dimer as a stand-alone test has been suggested.
We aimed to assess the safety and efficiency of D-dimer as a stand-alone test to rule out DVT in outpatients referred with suspected DVT.
We collected data from consecutive outpatients referred to our hospital with suspected DVT in 2008-2018. D-dimer levels were analyzed using STA® Liatest® D-Di assay. D-dimer as a stand-alone test was theoretically applied in retrospect, and the number of misdiagnosed events were estimated as if such an approach had been initially used. All patients were followed for three months.
Of 1765 included patients, 293 (16.6%) were diagnosed with DVT. A total of 491 patients (27.8%) had a negative D-dimer (<500 ng/mL). Of these, nine were diagnosed with DVT, yielding a failure rate for D-dimer as a stand-alone test of 1.8% (95% CI 0.8%-3.5%). The majority of the misdiagnosed patients had distal DVT. In analyses restricted to proximal DVTs, the failure rate was 0.6% (95% CI 0.1%-1.8%). D-dimer as a stand-alone approach reduced the proportion of required ultrasounds from 81.8% to 72.2%.
D-dimer as a stand-alone test may be safe for excluding proximal DVT and reduce the proportion of required ultrasounds. Prospective management studies are needed to confirm our findings.
目前的指南建议使用临床决策规则,如 Wells 评分,结合 D-二聚体来评估是否需要进行客观的影像学检查以排除深静脉血栓形成(DVT)。然而,临床决策规则存在局限性,并且已经提出将 D-二聚体作为单独的检测方法使用。
我们旨在评估 D-二聚体作为单独的检测方法在疑似 DVT 门诊患者中排除 DVT 的安全性和效率。
我们收集了 2008 年至 2018 年期间连续因疑似 DVT 就诊于我院的门诊患者的数据。使用 STA® Liatest® D-Di 测定法分析 D-二聚体水平。理论上回顾性地应用 D-二聚体作为单独的检测方法,并估计误诊事件的数量,就好像最初使用了这种方法一样。所有患者均随访 3 个月。
在纳入的 1765 例患者中,293 例(16.6%)被诊断为 DVT。共有 491 例(27.8%)患者的 D-二聚体<500ng/mL,其中 9 例被诊断为 DVT,D-二聚体作为单独检测方法的失败率为 1.8%(95%CI 0.8%-3.5%)。大多数误诊患者为远端 DVT。在仅限于近端 DVT 的分析中,失败率为 0.6%(95%CI 0.1%-1.8%)。D-二聚体作为单独的方法可将所需超声检查的比例从 81.8%降低至 72.2%。
D-二聚体作为单独的检测方法可能安全用于排除近端 DVT,并减少所需超声检查的比例。需要前瞻性管理研究来证实我们的发现。